English
简体中文
Total: £ 56.28
Published Date: 2025-08-12 | Pages: 90 | Tables: 88 | Pharma & Healthcare
The global market for Heparin API was valued at US$ 1225 million in the year 2024 and is projected to reach a revised size of US$ 2301 million by 2031, growing at a CAGR of 7.8% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Heparin API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Heparin API is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin API is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin API product is existed in a form of Heparin Sodium API or Heparin Calcium API.
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. In this report, we mainly study the Heparin API.
The market driver mainly increasing prevalence of conditions such as renal impairment, coronary artery disease, and venous thromboembolism, High demand for anticoagulants, etc.
The expanding healthcare sector, coupled with a rising prevalence of cardiovascular diseases and thrombotic disorders, continues to drive demand for Heparin Active Pharmaceutical Ingredient (API). The growing global aging population and increasing awareness about these medical conditions have further intensified the need for effective anticoagulant therapies. Additionally, advancements in medical research and development, alongside the escalating number of surgical procedures, contribute to the sustained growth of the Heparin API market. While, one of the significant challenges in the Heparin API market is the vulnerability of its supply chain. Dependence on porcine mucosa as the primary source, coupled with supply disruptions due to disease outbreaks and geopolitical factors, poses a risk to consistent availability. Moreover, ensuring the quality and safety of Heparin APIs remains a concern, with regulatory scrutiny focused on preventing adulteration and contamination. Balancing these challenges while navigating competition from alternative anticoagulants and addressing complex production processes poses ongoing difficulties for industry stakeholders.
The classification of Heparin includes Heparin Sodium and Heparin Calcium. In 2024, Heparin Sodium accounted for a revenue share of 96.63% in the global Heparin market. In addition, this product segment is poised to reach US$ 2,228.35 million by 2031 from US$ 1,184.01 million in 2024.
Heparin is widely used for UFH and LMWH. In Heparin market, the LMWH holds an important share in terms of application, and it is expected to reach a value of US$ 1,977.66 million by 2031, at a CAGR of 7.94% during 2025 and 2031.
Europe is the largest consumption place, with a revenue market share nearly 36.86% in 2024. China is the worlds’ largest pig production, which supplied by sufficient raw materials.
North American market for Heparin API is estimated to increase from $ 431.49 million in 2025 to reach $ 671.33 million by 2031, at a CAGR of 7.65% during the forecast period of 2025 through 2031.
Asia-Pacific market for Heparin API is estimated to increase from $ 478.50 million in 2025 to reach $ 799.46 million by 2031, at a CAGR of 8.93% during the forecast period of 2025 through 2031.
Europe market for Heparin API is estimated to increase from $ 537.57 million in 2025 to reach $ 801.22 million by 2031, at a CAGR of 6.88% during the forecast period of 2025 through 2031.
The global key companies of Heparin Active Pharmaceutical Ingredients include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, Bioibérica, Qingdao Jiulong Biopharmaceutical, Changzhou Qianhong Biopharma, and Dongying Tiandong Pharmaceutical, etc. In 2024, the global five largest players hold a share approximately 55.0% in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Heparin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin API.
The Heparin API market size, estimations, and forecasts are provided in terms of sales volume (Billion Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Heparin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heparin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Yantai Dongcheng Pharmaceutical
Shenzhen Hepalink Pharmaceutical
Pfizer
Nanjing King-friend Biochemical Pharmaceutical
Bioibérica
Changzhou Qianhong Biopharma
Hebei Changshan Biochemical Pharmaceutical
Qingdao Jiulong Biopharmaceutical
Opocrin
Dongying Tiandong Pharmaceutical
Aspen Oss
Yino Pharma
Hubei Enoray Biopharmaceutical
Cisen Pharmaceutical
Segment by Type
Heparin Sodium
Heparin Calcium
Segment by Application
UFH
LMWH
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Heparin API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Heparin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Heparin API Market Overview
1.1 Product Definition
1.2 Heparin API by Type
1.2.1 Global Heparin API Market Value Comparison by Type (2024 VS 2031)
1.2.2 Heparin Sodium
1.2.3 Heparin Calcium
1.3 Heparin API by Application
1.3.1 Global Heparin API Market Value by Application (2024 VS 2031)
1.3.2 UFH
1.3.3 LMWH
1.4 Global Heparin API Market Size Estimates and Forecasts
1.4.1 Global Heparin API Revenue 2020-2031
1.4.2 Global Heparin API Sales 2020-2031
1.4.3 Global Heparin API Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Heparin API Market Competition by Manufacturers
2.1 Global Heparin API Sales Market Share by Manufacturers (2020-2025)
2.2 Global Heparin API Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Heparin API Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Heparin API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Heparin API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Heparin API, Product Type & Application
2.7 Global Key Manufacturers of Heparin API, Date of Enter into This Industry
2.8 Global Heparin API Market Competitive Situation and Trends
2.8.1 Global Heparin API Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Heparin API Players Market Share by Revenue
2.8.3 Global Heparin API Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Heparin API Market Scenario by Region
3.1 Global Heparin API Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Heparin API Sales by Region: 2020-2031
3.2.1 Global Heparin API Sales by Region: 2020-2025
3.2.2 Global Heparin API Sales by Region: 2026-2031
3.3 Global Heparin API Revenue by Region: 2020-2031
3.3.1 Global Heparin API Revenue by Region: 2020-2025
3.3.2 Global Heparin API Revenue by Region: 2026-2031
3.4 North America Heparin API Market Facts & Figures by Country
3.4.1 North America Heparin API Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Heparin API Sales by Country (2020-2031)
3.4.3 North America Heparin API Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Heparin API Market Facts & Figures by Country
3.5.1 Europe Heparin API Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Heparin API Sales by Country (2020-2031)
3.5.3 Europe Heparin API Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Heparin API Market Facts & Figures by Region
3.6.1 Asia Pacific Heparin API Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Heparin API Sales by Region (2020-2031)
3.6.3 Asia Pacific Heparin API Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Heparin API Market Facts & Figures by Country
3.7.1 Latin America Heparin API Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Heparin API Sales by Country (2020-2031)
3.7.3 Latin America Heparin API Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Heparin API Market Facts & Figures by Country
3.8.1 Middle East and Africa Heparin API Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Heparin API Sales by Country (2020-2031)
3.8.3 Middle East and Africa Heparin API Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Heparin API Sales by Type (2020-2031)
4.1.1 Global Heparin API Sales by Type (2020-2025)
4.1.2 Global Heparin API Sales by Type (2026-2031)
4.1.3 Global Heparin API Sales Market Share by Type (2020-2031)
4.2 Global Heparin API Revenue by Type (2020-2031)
4.2.1 Global Heparin API Revenue by Type (2020-2025)
4.2.2 Global Heparin API Revenue by Type (2026-2031)
4.2.3 Global Heparin API Revenue Market Share by Type (2020-2031)
4.3 Global Heparin API Price by Type (2020-2031)
5 Segment by Application
5.1 Global Heparin API Sales by Application (2020-2031)
5.1.1 Global Heparin API Sales by Application (2020-2025)
5.1.2 Global Heparin API Sales by Application (2026-2031)
5.1.3 Global Heparin API Sales Market Share by Application (2020-2031)
5.2 Global Heparin API Revenue by Application (2020-2031)
5.2.1 Global Heparin API Revenue by Application (2020-2025)
5.2.2 Global Heparin API Revenue by Application (2026-2031)
5.2.3 Global Heparin API Revenue Market Share by Application (2020-2031)
5.3 Global Heparin API Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Yantai Dongcheng Pharmaceutical
6.1.1 Yantai Dongcheng Pharmaceutical Company Information
6.1.2 Yantai Dongcheng Pharmaceutical Description and Business Overview
6.1.3 Yantai Dongcheng Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Yantai Dongcheng Pharmaceutical Heparin API Product Portfolio
6.1.5 Yantai Dongcheng Pharmaceutical Recent Developments/Updates
6.2 Shenzhen Hepalink Pharmaceutical
6.2.1 Shenzhen Hepalink Pharmaceutical Company Information
6.2.2 Shenzhen Hepalink Pharmaceutical Description and Business Overview
6.2.3 Shenzhen Hepalink Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Shenzhen Hepalink Pharmaceutical Heparin API Product Portfolio
6.2.5 Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Heparin API Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer Heparin API Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Nanjing King-friend Biochemical Pharmaceutical
6.4.1 Nanjing King-friend Biochemical Pharmaceutical Company Information
6.4.2 Nanjing King-friend Biochemical Pharmaceutical Description and Business Overview
6.4.3 Nanjing King-friend Biochemical Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Nanjing King-friend Biochemical Pharmaceutical Heparin API Product Portfolio
6.4.5 Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates
6.5 Bioibérica
6.5.1 Bioibérica Company Information
6.5.2 Bioibérica Description and Business Overview
6.5.3 Bioibérica Heparin API Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bioibérica Heparin API Product Portfolio
6.5.5 Bioibérica Recent Developments/Updates
6.6 Changzhou Qianhong Biopharma
6.6.1 Changzhou Qianhong Biopharma Company Information
6.6.2 Changzhou Qianhong Biopharma Description and Business Overview
6.6.3 Changzhou Qianhong Biopharma Heparin API Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Changzhou Qianhong Biopharma Heparin API Product Portfolio
6.6.5 Changzhou Qianhong Biopharma Recent Developments/Updates
6.7 Hebei Changshan Biochemical Pharmaceutical
6.7.1 Hebei Changshan Biochemical Pharmaceutical Company Information
6.7.2 Hebei Changshan Biochemical Pharmaceutical Description and Business Overview
6.7.3 Hebei Changshan Biochemical Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hebei Changshan Biochemical Pharmaceutical Heparin API Product Portfolio
6.7.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
6.8 Qingdao Jiulong Biopharmaceutical
6.8.1 Qingdao Jiulong Biopharmaceutical Company Information
6.8.2 Qingdao Jiulong Biopharmaceutical Description and Business Overview
6.8.3 Qingdao Jiulong Biopharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Qingdao Jiulong Biopharmaceutical Heparin API Product Portfolio
6.8.5 Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
6.9 Opocrin
6.9.1 Opocrin Company Information
6.9.2 Opocrin Description and Business Overview
6.9.3 Opocrin Heparin API Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Opocrin Heparin API Product Portfolio
6.9.5 Opocrin Recent Developments/Updates
6.10 Dongying Tiandong Pharmaceutical
6.10.1 Dongying Tiandong Pharmaceutical Company Information
6.10.2 Dongying Tiandong Pharmaceutical Description and Business Overview
6.10.3 Dongying Tiandong Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Dongying Tiandong Pharmaceutical Heparin API Product Portfolio
6.10.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
6.11 Aspen Oss
6.11.1 Aspen Oss Company Information
6.11.2 Aspen Oss Description and Business Overview
6.11.3 Aspen Oss Heparin API Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Aspen Oss Heparin API Product Portfolio
6.11.5 Aspen Oss Recent Developments/Updates
6.12 Yino Pharma
6.12.1 Yino Pharma Company Information
6.12.2 Yino Pharma Description and Business Overview
6.12.3 Yino Pharma Heparin API Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Yino Pharma Heparin API Product Portfolio
6.12.5 Yino Pharma Recent Developments/Updates
6.13 Hubei Enoray Biopharmaceutical
6.13.1 Hubei Enoray Biopharmaceutical Company Information
6.13.2 Hubei Enoray Biopharmaceutical Description and Business Overview
6.13.3 Hubei Enoray Biopharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Hubei Enoray Biopharmaceutical Heparin API Product Portfolio
6.13.5 Hubei Enoray Biopharmaceutical Recent Developments/Updates
6.14 Cisen Pharmaceutical
6.14.1 Cisen Pharmaceutical Company Information
6.14.2 Cisen Pharmaceutical Description and Business Overview
6.14.3 Cisen Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Cisen Pharmaceutical Heparin API Product Portfolio
6.14.5 Cisen Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Heparin API Industry Chain Analysis
7.2 Heparin API Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Heparin API Production Mode & Process Analysis
7.4 Heparin API Sales and Marketing
7.4.1 Heparin API Sales Channels
7.4.2 Heparin API Distributors
7.5 Heparin API Customer Analysis
8 Heparin API Market Dynamics
8.1 Heparin API Industry Trends
8.2 Heparin API Market Drivers
8.3 Heparin API Market Challenges
8.4 Heparin API Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Heparin API Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Heparin API Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Heparin API Market Competitive Situation by Manufacturers in 2024
Table 4. Global Heparin API Sales (Billion Units) of Key Manufacturers (2020-2025)
Table 5. Global Heparin API Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Heparin API Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Heparin API Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Heparin API Average Price (USD/Billion Units) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Heparin API, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Heparin API, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Heparin API, Product Type & Application
Table 12. Global Key Manufacturers of Heparin API, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Heparin API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin API as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Heparin API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Heparin API Sales by Region (2020-2025) & (Billion Units)
Table 18. Global Heparin API Sales Market Share by Region (2020-2025)
Table 19. Global Heparin API Sales by Region (2026-2031) & (Billion Units)
Table 20. Global Heparin API Sales Market Share by Region (2026-2031)
Table 21. Global Heparin API Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Heparin API Revenue Market Share by Region (2020-2025)
Table 23. Global Heparin API Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Heparin API Revenue Market Share by Region (2026-2031)
Table 25. North America Heparin API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Heparin API Sales by Country (2020-2025) & (Billion Units)
Table 27. North America Heparin API Sales by Country (2026-2031) & (Billion Units)
Table 28. North America Heparin API Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Heparin API Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Heparin API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Heparin API Sales by Country (2020-2025) & (Billion Units)
Table 32. Europe Heparin API Sales by Country (2026-2031) & (Billion Units)
Table 33. Europe Heparin API Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Heparin API Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Heparin API Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Heparin API Sales by Region (2020-2025) & (Billion Units)
Table 37. Asia Pacific Heparin API Sales by Region (2026-2031) & (Billion Units)
Table 38. Asia Pacific Heparin API Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Heparin API Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Heparin API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Heparin API Sales by Country (2020-2025) & (Billion Units)
Table 42. Latin America Heparin API Sales by Country (2026-2031) & (Billion Units)
Table 43. Latin America Heparin API Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Heparin API Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Heparin API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Heparin API Sales by Country (2020-2025) & (Billion Units)
Table 47. Middle East and Africa Heparin API Sales by Country (2026-2031) & (Billion Units)
Table 48. Middle East and Africa Heparin API Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Heparin API Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Heparin API Sales (Billion Units) by Type (2020-2025)
Table 51. Global Heparin API Sales (Billion Units) by Type (2026-2031)
Table 52. Global Heparin API Sales Market Share by Type (2020-2025)
Table 53. Global Heparin API Sales Market Share by Type (2026-2031)
Table 54. Global Heparin API Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Heparin API Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Heparin API Revenue Market Share by Type (2020-2025)
Table 57. Global Heparin API Revenue Market Share by Type (2026-2031)
Table 58. Global Heparin API Price (USD/Billion Units) by Type (2020-2025)
Table 59. Global Heparin API Price (USD/Billion Units) by Type (2026-2031)
Table 60. Global Heparin API Sales (Billion Units) by Application (2020-2025)
Table 61. Global Heparin API Sales (Billion Units) by Application (2026-2031)
Table 62. Global Heparin API Sales Market Share by Application (2020-2025)
Table 63. Global Heparin API Sales Market Share by Application (2026-2031)
Table 64. Global Heparin API Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Heparin API Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Heparin API Revenue Market Share by Application (2020-2025)
Table 67. Global Heparin API Revenue Market Share by Application (2026-2031)
Table 68. Global Heparin API Price (USD/Billion Units) by Application (2020-2025)
Table 69. Global Heparin API Price (USD/Billion Units) by Application (2026-2031)
Table 70. Yantai Dongcheng Pharmaceutical Company Information
Table 71. Yantai Dongcheng Pharmaceutical Description and Business Overview
Table 72. Yantai Dongcheng Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2020-2025)
Table 73. Yantai Dongcheng Pharmaceutical Heparin API Product
Table 74. Yantai Dongcheng Pharmaceutical Recent Developments/Updates
Table 75. Shenzhen Hepalink Pharmaceutical Company Information
Table 76. Shenzhen Hepalink Pharmaceutical Description and Business Overview
Table 77. Shenzhen Hepalink Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2020-2025)
Table 78. Shenzhen Hepalink Pharmaceutical Heparin API Product
Table 79. Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
Table 80. Pfizer Company Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2020-2025)
Table 83. Pfizer Heparin API Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Nanjing King-friend Biochemical Pharmaceutical Company Information
Table 86. Nanjing King-friend Biochemical Pharmaceutical Description and Business Overview
Table 87. Nanjing King-friend Biochemical Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2020-2025)
Table 88. Nanjing King-friend Biochemical Pharmaceutical Heparin API Product
Table 89. Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates
Table 90. Bioibérica Company Information
Table 91. Bioibérica Description and Business Overview
Table 92. Bioibérica Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2020-2025)
Table 93. Bioibérica Heparin API Product
Table 94. Bioibérica Recent Developments/Updates
Table 95. Changzhou Qianhong Biopharma Company Information
Table 96. Changzhou Qianhong Biopharma Description and Business Overview
Table 97. Changzhou Qianhong Biopharma Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2020-2025)
Table 98. Changzhou Qianhong Biopharma Heparin API Product
Table 99. Changzhou Qianhong Biopharma Recent Developments/Updates
Table 100. Hebei Changshan Biochemical Pharmaceutical Company Information
Table 101. Hebei Changshan Biochemical Pharmaceutical Description and Business Overview
Table 102. Hebei Changshan Biochemical Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2020-2025)
Table 103. Hebei Changshan Biochemical Pharmaceutical Heparin API Product
Table 104. Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
Table 105. Qingdao Jiulong Biopharmaceutical Company Information
Table 106. Qingdao Jiulong Biopharmaceutical Description and Business Overview
Table 107. Qingdao Jiulong Biopharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2020-2025)
Table 108. Qingdao Jiulong Biopharmaceutical Heparin API Product
Table 109. Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
Table 110. Opocrin Company Information
Table 111. Opocrin Description and Business Overview
Table 112. Opocrin Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2020-2025)
Table 113. Opocrin Heparin API Product
Table 114. Opocrin Recent Developments/Updates
Table 115. Dongying Tiandong Pharmaceutical Company Information
Table 116. Dongying Tiandong Pharmaceutical Description and Business Overview
Table 117. Dongying Tiandong Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2020-2025)
Table 118. Dongying Tiandong Pharmaceutical Heparin API Product
Table 119. Dongying Tiandong Pharmaceutical Recent Developments/Updates
Table 120. Aspen Oss Company Information
Table 121. Aspen Oss Description and Business Overview
Table 122. Aspen Oss Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2020-2025)
Table 123. Aspen Oss Heparin API Product
Table 124. Aspen Oss Recent Developments/Updates
Table 125. Yino Pharma Company Information
Table 126. Yino Pharma Description and Business Overview
Table 127. Yino Pharma Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2020-2025)
Table 128. Yino Pharma Heparin API Product
Table 129. Yino Pharma Recent Developments/Updates
Table 130. Hubei Enoray Biopharmaceutical Company Information
Table 131. Hubei Enoray Biopharmaceutical Description and Business Overview
Table 132. Hubei Enoray Biopharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2020-2025)
Table 133. Hubei Enoray Biopharmaceutical Heparin API Product
Table 134. Hubei Enoray Biopharmaceutical Recent Developments/Updates
Table 135. Cisen Pharmaceutical Company Information
Table 136. Cisen Pharmaceutical Description and Business Overview
Table 137. Cisen Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2020-2025)
Table 138. Cisen Pharmaceutical Heparin API Product
Table 139. Cisen Pharmaceutical Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Heparin API Distributors List
Table 143. Heparin API Customers List
Table 144. Heparin API Market Trends
Table 145. Heparin API Market Drivers
Table 146. Heparin API Market Challenges
Table 147. Heparin API Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Heparin API
Figure 2. Global Heparin API Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Heparin API Market Share by Type: 2024 & 2031
Figure 4. Heparin Sodium Product Picture
Figure 5. Heparin Calcium Product Picture
Figure 6. Global Heparin API Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Heparin API Market Share by Application: 2024 & 2031
Figure 8. UFH
Figure 9. LMWH
Figure 10. Global Heparin API Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Heparin API Market Size (2020-2031) & (US$ Million)
Figure 12. Global Heparin API Sales (2020-2031) & (Billion Units)
Figure 13. Global Heparin API Average Price (USD/Billion Units) & (2020-2031)
Figure 14. Heparin API Report Years Considered
Figure 15. Heparin API Sales Share by Manufacturers in 2024
Figure 16. Global Heparin API Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Heparin API Players: Market Share by Revenue in Heparin API in 2024
Figure 18. Heparin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Heparin API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Heparin API Sales Market Share by Country (2020-2031)
Figure 21. North America Heparin API Revenue Market Share by Country (2020-2031)
Figure 22. U.S. Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Heparin API Sales Market Share by Country (2020-2031)
Figure 25. Europe Heparin API Revenue Market Share by Country (2020-2031)
Figure 26. Germany Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Heparin API Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Heparin API Revenue Market Share by Region (2020-2031)
Figure 33. China Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Taiwan Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Philippines Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Heparin API Sales Market Share by Country (2020-2031)
Figure 44. Latin America Heparin API Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Heparin API Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Heparin API Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. U.A.E Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Heparin API by Type (2020-2031)
Figure 54. Global Revenue Market Share of Heparin API by Type (2020-2031)
Figure 55. Global Heparin API Price (USD/Billion Units) by Type (2020-2031)
Figure 56. Global Sales Market Share of Heparin API by Application (2020-2031)
Figure 57. Global Revenue Market Share of Heparin API by Application (2020-2031)
Figure 58. Global Heparin API Price (USD/Billion Units) by Application (2020-2031)
Figure 59. Heparin API Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
